Fri, March 11, 2022

Douglas Tsao Maintained (TXMD) at Strong Buy with Decreased Target to $125 on, Mar 11th, 2022

Douglas Tsao of HC Wainwright & Co., Maintained "TherapeuticsMD, Inc." (TXMD) at Strong Buy with Decreased Target from $150 to $125 on, Mar 11th, 2022.

Douglas, nor any peers, have made any analyst calls on TXMD in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30